TLR2 and infection: Two days after infection, the mice treated with TLR2 inhibitors had obviously reduced release of inflammatory factors such as IL-6 and MCP-1, and the survival rate of SARS-CoV-2-infected mice was obviously improved (Zheng et al., 2021).